http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2570657-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5ea5dcc3f5fd9ed3749c2e254484b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4841
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B29-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085b3f4319f459c562d035842b794176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_391a9e8c14302dd516d03b5fcae1d635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94ba119cf3bcd9d594f05b2d6fb1f740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bbc70377739037ed4cfc9053153f8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e1695266ab80edafa81d96a7504ee15
publicationDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2570657-T3
titleOfInvention A crystalline form of (R) -7-chloro-n- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide monohydrate hydrochloride
abstract A crystalline form I of (R) -7-chloro-N- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide monohydrate hydrochloride, characterized by a powder X-ray diffractogram having peaks expressed as 2θ at one or both of 17.48 and 20.58 ± 0.20 degrees when measured against an internal silicon pattern, and characterized by an X-ray powder diffractogram that also has at least four peaks, six peaks, eight peaks or all peaks expressed as 2θ to 4.50, 9.04, 14.60, 15.14, 15.80, 16.60, 18.16, 18.44, 19.48, 21.74, and 25.46 ± 0.20 degrees when measured against an internal silicon pattern.
priorityDate 2010-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5461123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559541

Total number of triples: 34.